Mouse IL-33 Antibody Summary
Ser109-Ile266
Accession # Q8BVZ5
Applications
Please Note: Optimal dilutions should be determined by each laboratory for each application. General Protocols are available in the Technical Information section on our website.
Scientific Data
Detection of Mouse IL‑33 by Western Blot. Western blot shows lysates of mouse splenocytes. PVDF membrane was probed with 0.5 µg/mL of Rat Anti-Mouse IL-33 Monoclonal Antibody (Catalog # MAB3626) followed by HRP-conjugated Anti-Rat IgG Secondary Antibody (Catalog # HAF005). Specific bands were detected for IL-33 at approximately 18 and 35 kDa (as indicated). This experiment was conducted under reducing conditions and using Immunoblot Buffer Group 1.
IL‑33 in bEnd.3 Mouse Cell Line. IL-33 was detected in immersion fixed bEnd.3 mouse endothelioma cell line using Rat Anti-Mouse IL-33 Monoclonal Antibody (Catalog # MAB3626) at 10 µg/mL for 3 hours at room temperature. Cells were stained using the NorthernLights™ 557-conjugated Anti-Rat IgG Secondary Antibody (red, upper panel, Catalog # NL013) and counterstained with DAPI (blue, lower panel). View our protocol for Fluorescent ICC Staining of Cells on Coverslips.
Detection of IL‑33 in bEnd.3 Mouse Cell Line by Flow Cytometry. bEnd.3 mouse endothelioma cell line was stained with Rat Anti-Mouse IL-33 Monoclonal Antibody (Catalog # MAB3626, filled histogram) or isotype control antibody (Catalog # MAB006, open histogram), followed by Phycoerythrin-conjugated Anti-Rat IgG Secondary Antibody (Catalog # F0105B). To facilitate intracellular staining, cells were fixed with Flow Cytometry Fixation Buffer (Catalog # FC004) and permeabilized with Flow Cytometry Permeabilization/Wash Buffer I (Catalog # FC005). View our protocol for Staining Intracellular Molecules.
Reconstitution Calculator
Preparation and Storage
- 12 months from date of receipt, -20 to -70 °C as supplied.
- 1 month, 2 to 8 °C under sterile conditions after reconstitution.
- 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Background: IL-33
IL-33, also known as NF-HEV and DVS 27, is a 30 kDa proinflammatory protein that may also regulate gene transcription (1-3). DVS 27 was identifed as a gene that is upregulated in vasospastic cerebral arteries (1). NF-HEV was described as a nuclear factor that is preferentially expressed in the endothelial cells of high endothelial venules relative to endothelial cells from other tissues (2). IL-33 was identified based on sequence and structural homology with IL-1 family cytokines (3). DVS 27, NF-HEV, and IL-33 share 100% amino acid sequence identity. IL-33 is constitutively expressed in smooth muscle and airway epithelia. It is upregulated in arterial smooth muscle, dermal fibroblasts, and keratinocytes following IL-1 alpha or IL-1 beta stimulation (1, 3). Similar to IL-1, IL-33 can be cleaved in vitro by caspase-1, generating an N-terminal fragment that is slightly shorter than the C-terminal fragment (3, 4). The N-terminal portion of full length IL-33 contains a predicted bipartite nuclear localization sequence and a homeodomain-like helix-turn-helix DNA binding domain. By immunofluorescence, full length IL-33 localizes to the nucleus in HUVECs and transfectants (2). The C-terminal fragment, corresponding to mature IL-33, binds and triggers signaling through mast cell IL-1 R4/ST2L, a longtime orphan receptor involved in the augmentation of Th2 cell responses (3, 5-7). A ternary signaling complex is formed by the subsequent association of IL-33 and ST2L with IL-1R AcP (8). Stimulation of Th2 polarized lymphocytes with mature IL-33 in vitro induces IL-5 and IL-13 secretion (3). In vivo administration of mature IL-33 promotes increased production of IL-5, IL-13, IgE, and IgA, as well as splenomegaly and inflammatory infiltration of mucosal tissues (3). Full length and mature mouse IL-33 share approximately 55% and 90% amino acid (aa) sequence identity with human and rat IL-33, respectively. Mouse IL-33 shares less than 25% aa sequence identity with other IL-1 family proteins.
- Onda, H. et al. (1999) J. Cereb. Blood Flow Metab. 19:1279.
- Baekkevold, E.S. et al. (2003) Am. J. Pathol. 163:69.
- Schmitz, J. et al. (2005) Immunity 23:479.
- Black, R.A. et al. (1989) J. Biol. Chem. 264:5323.
- Xu, D. et al. (1998) J. Exp. Med. 187:787.
- Lohning, M. et al. (1998) Proc. Natl. Acad. Sci. USA 95:6930.
- Dinarello, C.A. (2005) Immunity 23:461.
- Chackerian, A.A. et al. (2007) J. Immunol. 179:2551.
Product Datasheets
Citations for Mouse IL-33 Antibody
R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.
26
Citations: Showing 1 - 10
Filter your results:
Filter by:
-
Interleukin 33 regulates gene expression in intestinal epithelial cells independently of its nuclear localization
Authors: Z He, L Chen, GC Furtado, SA Lira
Cytokine, 2018-08-23;111(0):146-153.
-
Single-cell transcriptomic analysis of the identity and function of fibro/adipogenic progenitors in healthy and dystrophic muscle
Authors: Uapinyoying P, Hogarth M, Battacharya S et al.
iScience
-
Gata3 is detrimental to regulatory T cell function in autoimmune diabetes
Authors: B Kiaf, K Bode, C Schuster, S Kissler
bioRxiv : the preprint server for biology, 2023-03-23;0(0):.
Species: Mouse
Sample Types: Cell Lysates
Applications: Western Blot -
Loss of SLC26A3 Results in Colonic Mucosal Immune Dysregulation via Epithelial-Immune Cell Crosstalk
Authors: D Jayawarden, S Priyamvada, T Kageyama, Z White, A Kumar, TF Griggs, A Majumder, R Akram, AN Anbazhagan, T Sano, PK Dudeja
Cellular and Molecular Gastroenterology and Hepatology, 2022-12-17;0(0):.
Species: Mouse, Transgenic Mouse
Sample Types: In Vivo
Applications: In Vivo -
IL-33 enhances Jagged1 mediated NOTCH1 intracellular domain (NICD) deubiquitination and pathological angiogenesis in proliferative retinopathy
Authors: Deepti Sharma, Shivantika Bisen, Geetika Kaur, Eric C. Van Buren, Gadiparthi N. Rao, Nikhlesh K. Singh
Communications Biology
-
Myeloid-IL4Ralpha is an indispensable link in IL-33-ILCs-IL-13-IL4Ralpha axis of eosinophil recruitment in murine lungs
Authors: S Patial, BW Lewis, T Vo, I Choudhary, K Paudel, Y Mao, D Singamsett, F Brombacher, Y Saini
Scientific Reports, 2021-07-29;11(1):15465.
Species: Mouse
Sample Types: Whole Tissue
Applications: IHC -
Regulatory T Cells Exhibit Interleukin-33-Dependent Migratory Behavior during Skin Barrier Disruption
Authors: S Toyama, CS Moniaga, S Nakae, M Kurosawa, H Ogawa, M Tominaga, K Takamori
International Journal of Molecular Sciences, 2021-07-12;22(14):.
Species: Mouse
Sample Types: In Vivo
Applications: Neutralization -
Loss of the adhesion G-protein coupled receptor ADGRF5 in mice induces airway inflammation and the expression of CCL2 in lung endothelial cells
Authors: F Kubo, DM Ariestanti, S Oki, T Fukuzawa, R Demizu, T Sato, RM Sabirin, S Hirose, N Nakamura
Respir. Res., 2019-01-17;20(1):11.
Species: Mouse
Sample Types: Tissue Homogenates
Applications: Western Blot -
The therapeutic effect of anti-CD52 treatment in murine experimental autoimmune encephalomyelitis is associated with altered IL-33 and ST2 expression levels
Authors: Mark Barbour, Rachel Wood, Shehla U. Hridi, Chelsey Wilson, Grant McKay, Trevor J. Bushell et al.
Journal of Neuroimmunology
-
Macrophages produce IL-33 by activating MAPK signaling pathway during RSV infection
Authors: F Qi, S Bai, D Wang, L Xu, H Hu, S Zeng, R Chai, B Liu
Mol. Immunol., 2017-05-19;87(0):284-292.
Species: Mouse
Sample Types: Cell Lysates
Applications: Western Blot -
Aspirin-Exacerbated Respiratory Disease Involves a Cysteinyl Leukotriene-Driven IL-33-Mediated Mast Cell Activation Pathway.
Authors: Liu T, Kanaoka Y, Barrett N, Feng C, Garofalo D, Lai J, Buchheit K, Bhattacharya N, Laidlaw T, Katz H, Boyce J
J Immunol, 2015-09-04;195(8):3537-45.
Species: Mouse
Sample Types: Whole Tissue
Applications: IHC-P -
IL-33 is required for disposal of unnecessary cells during ovarian atresia through regulation of autophagy and macrophage migration.
Authors: Wu J, Carlock C, Zhou C, Nakae S, Hicks J, Adams H, Lou Y
J Immunol, 2015-01-23;194(5):2140-7.
Species: Mouse
Sample Types: Whole Tissue
Applications: IHC -
Neutrophils prime a long-lived effector macrophage phenotype that mediates accelerated helminth expulsion.
Authors: Chen, Fei, Wu, Wenhui, Millman, Ariel, Craft, Joshua F, Chen, Eunice, Patel, Nirav, Boucher, Jean L, Urban, Joseph F, Kim, Charles, Gause, William
Nat Immunol, 2014-08-31;15(10):938-46.
Species: Mouse
Sample Types: Whole Cells
Applications: Flow Cytometry -
The alarmin IL-33 promotes regulatory T-cell function in the intestine.
Authors: Schiering C, Krausgruber T, Chomka A, Frohlich A, Adelmann K, Wohlfert E, Pott J, Griseri T, Bollrath J, Hegazy A, Harrison O, Owens B, Lohning M, Belkaid Y, Fallon P, Powrie F
Nature, 2014-07-16;513(7519):564-8.
Species: Mouse
Sample Types: Cell Lysates
Applications: Western Blot -
Unique temporal and spatial expression patterns of IL-33 in ovaries during ovulation and estrous cycle are associated with ovarian tissue homeostasis.
Authors: Carlock C, Wu J, Zhou C, Tatum K, Adams H, Tan F, Lou Y
J Immunol, 2014-05-23;193(1):161-9.
Species: Mouse
Sample Types: In Vivo
Applications: Neutralization -
alpha-Galactosylceramide but not phenyl-glycolipids induced NKT cell anergy and IL-33-mediated myeloid-derived suppressor cell accumulation via upregulation of egr2/3.
Authors: Huang J, Tsai Y, Chang Y, Wu J, Hung J, Lin K, Wong C, Yu A
J Immunol, 2014-01-24;192(4):1972-81.
Species: Mouse
Sample Types: Whole Cells
Applications: Flow Cytometry -
IL-33 targeting attenuates intestinal mucositis and enhances effective tumor chemotherapy in mice.
Authors: Guabiraba R, Besnard A, Menezes G, Secher T, Jabir M, Amaral S, Braun H, Lima-Junior R, Ribeiro R, Cunha F, Teixeira M, Beyaert R, Graham G, Liew F
Mucosal Immunol, 2014-01-15;7(5):1079-93.
Species: Mouse
Sample Types: In Vivo, Whole Tissue
Applications: IHC, Neutralization -
Interleukin-33 and alveolar macrophages contribute to the mechanisms underlying the exacerbation of IgE-mediated airway inflammation and remodelling in mice.
Authors: Mizutani N, Nabe T, Yoshino S
Immunology, 2013-06-01;139(2):205-18.
Species: Mouse
Sample Types: In Vivo
Applications: Neutralization -
Apoptotic cell clearance by bronchial epithelial cells critically influences airway inflammation.
Authors: Juncadella, Ignacio, Kadl, Alexandr, Sharma, Ashish K, Shim, Yun M, Hochreiter-Hufford, Amelia, Borish, Larry, Ravichandran, Kodi S
Nature, 2012-12-12;493(7433):547-51.
Species: Mouse
Sample Types: In Vivo
Applications: Neutralization -
Inducible IL-33 expression by mast cells is regulated by a calcium-dependent pathway.
Authors: Hsu C, Bryce P
J Immunol, 2012-08-24;189(7):3421-9.
Species: Mouse
Sample Types: Whole Cells
Applications: ICC -
IL-33 attenuates EAE by suppressing IL-17 and IFN-gamma production and inducing alternatively activated macrophages.
Authors: Jiang HR, Milovanovic M, Allan D, Niedbala W, Besnard AG, Fukada SY, Alves-Filho JC, Togbe D, Goodyear CS, Linington C, Xu D, Lukic ML, Liew FY
Eur. J. Immunol., 2012-06-12;42(7):1804-14.
Species: Mouse
Sample Types: Whole Tissue
Applications: IHC-Fr -
Production and functions of IL-33 in the central nervous system.
Authors: Yasuoka S, Kawanokuchi J, Parajuli B, Jin S, Doi Y, Noda M, Sonobe Y, Takeuchi H, Mizuno T, Suzumura A
Brain Res., 2011-02-22;1385(0):8-17.
Species: Mouse
Sample Types: Cell Lysates, Whole Tissue
Applications: IHC-Fr, Western Blot -
IL-33 is produced by mast cells and regulates IgE-dependent inflammation.
Authors: Hsu CL, Neilsen CV, Bryce PJ
PLoS ONE, 2010-08-03;5(8):e11944.
Species: Mouse
Sample Types: Whole Cells
Applications: Flow Cytometry -
Induction of IL-33 expression and activity in central nervous system glia.
Authors: Hudson CA, Christophi GP, Gruber RC, Wilmore JR, Lawrence DA, Massa PT
J. Leukoc. Biol., 2008-06-13;84(3):631-43.
Species: Mouse
Sample Types: Cell Culture Supernates
Applications: ELISA Development -
Osteoblast Hypoxia-Inducible Factor-1a Pathway Activation Restrains Osteoclastogenesis via the Interleukin-33-MicroRNA-34a-Notch1 Pathway.
Authors: Kang H, Yang K, Xiao L et al.
Front Immunol.
-
Interleukin-33 primes mast cells for activation by IgG immune complexes.
Authors: Kaieda S, Wang J, Shnayder R, Fishgal N, Hei H, Lee R, Stevens R, Nigrovic P
PLoS ONE, 2012-10-11;7(10):e47252.
FAQs
No product specific FAQs exist for this product, however you may
View all Antibody FAQsReviews for Mouse IL-33 Antibody
Average Rating: 4.8 (Based on 4 Reviews)
Have you used Mouse IL-33 Antibody?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
Filter by: